Sight Sciences to Feature Interactive Panel Discussions of Real-World Use of the Omni Surgical System as a Standalone Glaucoma Treatment at AAO

Sight Sciences announced that 12 ophthalmic physicians will present their first-hand experience using the Omni Surgical System as a standalone minimally invasive glaucoma surgery (MIGS) during this year’s annual AAO convention at McCormick Place in Chicago. Meeting delegates are invited to attend the four sessions throughout the weekend at the Sight Sciences booth (#4843) to learn more about Omni standalone treatment and engage directly with the panelists. Additionally, the soon to be released Ergo-Series of the Omni Surgical System and the recently launched Sion Surgical Instrument will be showcased at AAO 2022 and available for hands-on demos at the booth.

“The Omni Surgical System has changed the way physicians approach glaucoma surgery,” Cathleen McCabe, Chief Medical Officer of Eye Health America and Medical Director of The Eye Associates in Bradenton and Sarasota, FL, said in a company news release. “As a minimally invasive, implant-free standalone treatment, Omni allows surgeons to lower IOP and reduce a patient’s medication burden while avoiding more aggressive surgical interventions. Having such an effective and safe standalone intervention is vital to serve the needs of our phakic and pseudophakic patients with glaucoma.”

Speaker Forum on Saturday, October 1:

• 11:00 AM - 11:45 PM CT: Standalone MIGS: Beyond Cataract Surgery 
  • Leon Herndon, MD (moderator); Deb Ristvedt, DO; Arkadiy Yadgarov, MD
• 1:30 PM - 2:15 PM CT: Standalone Use of the OMNI Surgical System 
  • Cathleen McCabe, MD (moderator); Jason Bacharach, MD; Jai Parekh, MD

Speaker Forum on Sunday, October 2:

• 10:00 AM - 10:45 AM CT: Why Standalone MIGS with the OMNI Surgical System? 
  • Paul Singh, MD (moderator); Analisa Arosemena, MD; Amir Cohen, MD
• 1:30 PM - 2:15 PM CT: Best practices in adopting Standalone MIGS 
  • Nathan Radcliffe, MD (moderator); Matthew Brink, MD; Zarmeena Vendal, MD

“The growth and adoption of Omni as a standalone treatment as evidenced by such a diverse and esteemed panel of speakers sharing their real-world experiences and clinical data, brings a sense of great anticipation to this year’s AAO meeting,” said Paul Badawi, CEO and co-founder of Sight Sciences. “We are also excited to demonstrate the continued evolution of our surgical portfolio by offering doctors hands-on access to the soon-to-be released Ergo-Series of the Omni Surgical System and the new Sion Surgical Instrument.”

Booth events are not part of the official AAO program. The 12 presenters are paid consultants of Sight Sciences.